טוען...

Discovery of CNS Penetrant CXCR2 Antagonists for the Potential Treatment of CNS Demyelinating Disorders

[Image: see text] Structure–activity relationship exploration of the historical biarylurea series led to the identification of novel CNS penetrant CXCR2 antagonists with nanomolar potency, favorable PK profile, and good developability potentials. More importantly, the key compound 22 showed efficacy...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:ACS Med Chem Lett
Main Authors: Xu, Heng, Lu, Hongfu, Xu, Zhongmiao, Luan, Linbo, Li, Chengyong, Xu, Yan, Dong, Kelly, Zhang, Jinqiang, Li, Xiong, Li, Yvonne, Liu, Gentao, Gong, Sophie, Zhao, Yong-Gang, Liu, Ailian, Zhang, Yueting, Zhang, Wei, Cai, Xin, Xiang, Jia-Ning, Elliott, John D., Lin, Xichen
פורמט: Artigo
שפה:Inglês
יצא לאור: American Chemical Society 2016
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4834652/
https://ncbi.nlm.nih.gov/pubmed/27096048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.5b00489
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!